Balentine LLC’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,815
| Closed | -$1.27M | – | 216 |
|
|
2024
Q1 | $1.27M | Buy |
18,815
+5,323
| +39% | +$361K | 0.04% | 153 |
|
|
2023
Q4 | $909K | Buy |
13,492
+8,621
| +177% | +$581K | 0.03% | 185 |
|
|
2023
Q3 | $330K | Sell |
4,871
-257
| -5% | -$17.4K | 0.01% | 347 |
|
|
2023
Q2 | $367K | Buy |
5,128
+264
| +5% | +$18.9K | 0.01% | 340 |
|
|
2023
Q1 | $338K | Buy |
4,864
+27
| +0.6% | +$1.87K | 0.01% | 378 |
|
|
2022
Q4 | $328K | Sell |
4,837
-893
| -16% | -$60.6K | 0.01% | 427 |
|
|
2022
Q3 | $314K | Sell |
5,730
-2,736
| -32% | -$150K | 0.01% | 382 |
|
|
2022
Q2 | $559K | Sell |
8,466
-4,598
| -35% | -$304K | 0.02% | 287 |
|
|
2022
Q1 | $867K | Buy |
13,064
+5,799
| +80% | +$385K | 0.03% | 195 |
|
|
2021
Q4 | $423K | Buy |
7,265
+1,352
| +23% | +$78.7K | 0.01% | 193 |
|
|
2021
Q3 | $355K | Sell |
5,913
-225
| -4% | -$13.5K | 0.01% | 158 |
|
|
2021
Q2 | $368K | Buy |
+6,138
| New | +$368K | 0.01% | 100 |
|
|
2020
Q3 | – | Sell |
-2,051
| Closed | -$108K | – | 205 |
|
|
2020
Q2 | $108K | Buy |
+2,051
| New | +$108K | 0.01% | 142 |
|
|
2019
Q4 | – | Sell |
-1,332
| Closed | -$59K | – | 611 |
|
|
2019
Q3 | $59K | Hold |
1,332
| – | – | ﹤0.01% | 121 |
|
|
2019
Q2 | $55K | Buy |
1,332
+170
| +15% | +$7.02K | ﹤0.01% | 101 |
|
|
2019
Q1 | $47K | Buy |
1,162
+515
| +80% | +$20.8K | ﹤0.01% | 125 |
|
|
2018
Q4 | $25K | Hold |
647
| – | – | ﹤0.01% | 168 |
|
|
2018
Q3 | $26K | Buy |
647
+167
| +35% | +$6.71K | ﹤0.01% | 114 |
|
|
2018
Q2 | $17K | Buy |
+480
| New | +$17K | ﹤0.01% | 72 |
|
|
2018
Q1 | – | Sell |
-1,488
| Closed | -$52K | – | 99 |
|
|
2017
Q4 | $52K | Sell |
1,488
-36
| -2% | -$1.26K | ﹤0.01% | 270 |
|
|
2017
Q3 | $52K | Buy |
+1,524
| New | +$52K | ﹤0.01% | 256 |
|